Sep 2026· Future Journal of Pharmaceuticals and Health Sciences· 0 citations
TL;DR
Discussing the effectiveness of the recent therapy for Huntington's illness is the main ambition in this regard, and a variety of treatments are accessible to lessen the symptoms of Hunti ngton's disorder, and efficient solutions for its chorea.
Abstract
Physical sign, behavioral, as well as increasing cognition are hallmarks of Huntington Disease (HD), a monogenic neurodegenerative illness that causes early impairment and death. In 1993, the genetic effect was identified as an enlarged Cytosine, Adenine, Guanine repeat on chromosome 4's exon 1 of the Huntington gene. The assessment of individuals who are clinically afflicted by Huntington's disease depends on the differential diagnosis. A variety of treatments are accessible to lessen the symptoms of Hunti ngton's disorder, and efficient solutions for its chorea. Additionally, RNA interference medicines are being developed for clinical use, antibody treatments, stem cell treatments, etc. Discussing the effectiveness of the recent therapy for Huntington's illness is the main ambition in this regard comprehen sive analysis.
Dual targeting of both huntingtin and somatic instability is a novel emerging therapeutic concept that provides additional hope for an effective disease modification in Huntington disease in the future.
Surabhi Garg, Tiago A. Mestre· Parkinsonism & Related Disor...· 0 citations
Rett syndrome (RTT) is a severe neurodevelopmental disorder characterized by multiple neurological impairments, which affects predominantly females. It is associated, in most cases, with pathogenic variants in MECP2, the gene encoding the methyl-CpG-binding protein 2. In the four decades since its description in the En...
Walter E. Kaufmann· Developmental Medicine & Chi...· 2 citations
We are in an era in which increasing numbers of potentially disease-modifying treatments for Parkinson's disease are being tested in clinical development. Current definitions of disease modification have inherent limitations; hence there is a need to establish a clear, unified definition. This unified definition of dis...
A. Antonini, Robert E. Gross, María Lucia De León et al.· Journal of Parkinson's Disea...· 0 citations
The urgent need for reliable biomarkers, early diagnosis, and multidisciplinary disease-modifying strategies for future therapeutic interventions is highlighted, with particular emphasis on challenges associated with bench-to-bedside translation.
Jeewanjot Singh, Subhi Sharma, Prabhjot Singh et al.· 0 citations
Huntington's Disease (HD) is a relentlessly progressive genetic disorder characterised by cognitive, behavioural and physical impairments. The lack of effective treatments, early onset of symptoms and high rates of suicide reflect a disease of significant human suffering. The ethical imperative to pursue disease modify...
